United States (USA) (US)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Editorial: Uncovering Drug Resistance During Cancer Therapy (2022) Wang H, Wang RH, Zhou J, Hou W, Wong AHH Journal article Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial (2022) Weber MA, Schmieder R, Kandzari DE, Townsend RR, Mahfoud F, Tsioufis K, Kario K, et al. Journal article Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) Dixon-Suen SC, Lewis SJ, Martin RM, English DR, Boyle T, Giles GG, Michailidou K, et al. Journal article Evidence of Magnon-Mediated Orbital Magnetism in a Quasi-2D Topological Magnon Insulator (2022) Alahmed L, Zhang X, Wen J, Xiong Y, Li Y, Zhang LC, Lux F, et al. Journal article Numerical study on the lubrication in total knee replacements: The influence of dynamics, geometry, material and fluid (2022) Marian M, Rothammer B, Bartz M, Nečas D, Vrbka M, Wimmer MA, Wartzack S Conference contribution, Conference Contribution Transient Motion Classification Through Turbid Volumes via Parallelized Single-Photon Detection and Deep Contrastive Embedding (2022) Xu S, Liu W, Yang X, Jönsson J, Qian R, McKee P, Kim K, et al. Journal article Models for Computer Science Teacher Preparation: Developing Teacher Knowledge (2022) Yadav A, Connolly C, Berges M, Chytas C, Franklin C, Hijón-Neira R, Leftwich A, et al. Conference contribution Steps Learners Take when Solving Programming Tasks, and How Learning Environments (Should) Respond to Them (2022) Jeuring J, Keuning H, Marwan S, Bouvier D, Izu C, Kiesler N, Lehtinen T, et al. Conference contribution Patient Characteristics and Treatment Patterns in European Pediatric Patients with Psoriasis: A Real-World, Cross-Sectional Study (2022) Sticherling M, Mcpherson T, Laguna RDL, Costanzo A, Reed C, Artime E, Robert C, et al. Journal article Cost-effectiveness of pembrolizumab plus chemotherapy as first-line treatment in PD-L1-positive metastatic triple-negative breast cancer (2022) Huang M, Fasching P, Haiderali A, Pan W, Gray E, Zhou ZY, Hu P, et al. Journal article